SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001626971-15-000002
Filing Date
2015-09-25
Accepted
2015-09-25 11:36:05
Documents
1
Effectiveness Date
2015-09-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9624
  Complete submission text file 0001626971-15-000002.txt   10672
Mailing Address 250 GOLDEN HILLS DRIVE PORTOLA VALLEY CA 94028-7613
Business Address 250 GOLDEN HILLS DRIVE PORTOLA VALLEY CA 94028-7613 650 245 6535
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1214
Type: D | Act: 33 | File No.: 021-248244 | Film No.: 151124529